SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1♦
暂无分享,去创建一个
Venkataraman Thanabal | Jessica Ward | Xiayang Qiu | R. Garofalo | B. Stockman | A. Varghese | David Cunningham | Matt Griffor | J. Withka | M. Griffor | B. Chrunyk | X. Qiu | Kay Ahn | Alison Varghese | V. Thanabal | Brandon Pabst | Boris Chrunyk | Michelle Pacholec | John E. Bleasdale | Declan Flynn | Robert S. Garofalo | David Griffith | Pat Loulakis | Brian Stockman | Jane Withka | Kay Ahn | J. E. Bleasdale | J. Ward | D. Cunningham | D. Flynn | P. Loulakis | Brandon A Pabst | M. Pacholec | D. Griffith
[1] Brian C. Smith,et al. Mechanisms and molecular probes of sirtuins. , 2008, Chemistry & biology.
[2] Amy V. Lynch,et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.
[3] L. Guarente,et al. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans , 2001, Nature.
[4] P. Puigserver,et al. Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.
[5] P. Distefano,et al. Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. , 2005, Journal of medicinal chemistry.
[6] S. Gasser,et al. The molecular biology of the SIR proteins. , 2001, Gene.
[7] M. McVey,et al. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. , 1999, Genes & development.
[8] J. Denu,et al. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases. , 2004, Biochemistry.
[9] Daisuke Koya,et al. SIRT1 and insulin resistance , 2009, Nature Reviews Endocrinology.
[10] V. Schramm,et al. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates. , 2004, Current medicinal chemistry.
[11] Sir2 deacetylases exhibit nucleophilic participation of acetyl-lysine in NAD+ cleavage. , 2007, Journal of the American Chemical Society.
[12] M. Permutt,et al. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. , 2005, Cell metabolism.
[13] Wei Chen,et al. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. , 1998, The Journal of clinical investigation.
[14] J. Boeke,et al. The biochemistry of sirtuins. , 2006, Annual review of biochemistry.
[15] R. Coppari,et al. Central administration of resveratrol improves diet-induced diabetes. , 2009, Endocrinology.
[16] J. Goldstein,et al. Molecular Characterization of Human Acetyl-CoA Synthetase, an Enzyme Regulated by Sterol Regulatory Element-binding Proteins* , 2000, The Journal of Biological Chemistry.
[17] Myriam Gorospe,et al. Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase , 2004, Science.
[18] K. Morikawa,et al. Kinetic properties and structural characterization of highly purified acetyl-CoA synthetase from bovine heart and tissue distribution of the enzyme in rat tissues. , 1995, The Tohoku journal of experimental medicine.
[19] Brian C. Smith,et al. Mechanism of Human SIRT1 Activation by Resveratrol* , 2005, Journal of Biological Chemistry.
[20] I. H. Segel. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems , 1975 .
[21] Alexander S Banks,et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. , 2008, Cell metabolism.
[22] John Nguyen,et al. Purification of recombinant p53 from Sf9 insect cells. , 2003, Methods in molecular biology.
[23] D. Groebe. Screening for positive allosteric modulators of biological targets. , 2006, Drug discovery today.
[24] W. C. Hallows,et al. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases , 2006, Proceedings of the National Academy of Sciences.
[25] Jasper Rine,et al. The establishment, inheritance, and function of silenced chromatin in Saccharomyces cerevisiae. , 2003, Annual review of biochemistry.
[26] B. Viollet,et al. AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol , 2009, Diabetes.
[27] Michael A. Tainsky,et al. Role for Human SIRT2 NAD-Dependent Deacetylase Activity in Control of Mitotic Exit in the Cell Cycle , 2003, Molecular and Cellular Biology.
[28] G. Reaven,et al. Insulin resistance as a predictor of age-related diseases. , 2001, The Journal of clinical endocrinology and metabolism.
[29] Shu-Chen Lu,et al. Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity , 2009, Chemical biology & drug design.
[30] S. Fields,et al. Substrate-specific Activation of Sirtuins by Resveratrol* , 2005, Journal of Biological Chemistry.
[31] Eric Ravussin,et al. Calorie Restriction Increases Muscle Mitochondrial Biogenesis in Healthy Humans , 2007, PLoS medicine.
[32] Yan-Hsiung Wang,et al. Identification and Characterization of a Novel p300-mediated p53 Acetylation Site, Lysine 305* , 2003, Journal of Biological Chemistry.
[33] Delin Chen,et al. Negative Control of p53 by Sir2α Promotes Cell Survival under Stress , 2001, Cell.
[34] David J. Gagne,et al. Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo , 2009, BMC Syst. Biol..
[35] R. Weinberg,et al. hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase , 2001, Cell.
[36] N. Oppenheimer,et al. Mechanism of Nicotinamide Inhibition and Transglycosidation by Sir2 Histone/Protein Deacetylases* , 2003, Journal of Biological Chemistry.
[37] D. Sinclair,et al. Sirtuins: a conserved key unlocking AceCS activity. , 2007, Trends in biochemical sciences.
[38] R. Cole,et al. Sir2-Dependent Activation of Acetyl-CoA Synthetase by Deacetylation of Active Lysine , 2002, Science.
[39] S. Minucci,et al. Human SIR2 deacetylates p53 and antagonizes PML/p53‐induced cellular senescence , 2002, The EMBO journal.
[40] E. Ravussin,et al. Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. , 2005, Obesity research.
[41] J. Auwerx,et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. , 2008, Cell metabolism.
[42] L. Polito,et al. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence. , 2010, Journal of Alzheimer's disease : JAD.
[43] M. Periasamy,et al. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. , 2010, American journal of physiology. Heart and circulatory physiology.
[44] P. Puigserver,et al. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.
[45] K. Tsuneyama,et al. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. , 2009, American journal of physiology. Endocrinology and metabolism.
[46] Yuzhi Zhang,et al. Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype. , 2010, Cardiovascular research.
[47] B. Rogina,et al. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.